Pharma

Your Article Summary

See Latest Articles

Sapphire Therapeutics, Inc. Expands Drug Development Team
Corporate News Releases - The Healthcare Sales & Marketing Network, 08/28/06

Sapphire Therapeutics, Inc., a private biopharmaceutical company developing compounds acting within the ghrelin pathway to treat cancer cachexia and other diseases, announced the appointment of Herbert Conrad as president and CEO, the addition of Bruce Peacock to the Board of Directors, and the internal promotion of William Mann to vice president, corporate development, to strengthen the company's team of pharmaceutical development experts advancing preclinical and clinical development of a growing therapeutic pipeline

Today in Execs on the Move...keeping you current

Receive free subspecialty "5-minute updates" via email

Medtronic Hires Renowned Cardiologist as Vice President of Medical Affairs for Coronary and Peripheral Business
Medtronic, 12/09/09

Robert J. Bertolini Elected to Genzyme's Board of Directors
Genzyme, 12/09/09

The Joint Commission Names Charles R. Buck to Board of Commissioners, Connie S. March to Represent Long Term Care Field
Joint Commission news, 12/07/09

 See all of Execs on the Move